Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Idavir
- Development stage
- Phase 4
- Lead developer
- Shandong Provincial Qianfoshan Hospital
- Administration
- Intraperitoneal
01
Overview
Idavir is a peritoneal dialysis solution indicated for the treatment of End-stage renal disease stage 5. Peritoneal dialysis solutions function by establishing an osmotic gradient across the peritoneal membrane, facilitating the removal of metabolic waste products and excess fluid from the patient's blood into the dialysate. This process helps to manage the symptoms and complications associated with severe kidney failure.
- Other names
- 依达维腹膜透析液
Beyond the preview
Go deeper on Idavir.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Idavir.